Trial Profile
Randomized Double Blind Placebo Controlled PK/PD Study on the Effects of a Single Intravenous Dose of NOX-H94 on Serum Iron During Experimental Human Endotoxemia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Jul 2022
Price :
$35
*
At a glance
- Drugs Lexaptepid pegol (Primary)
- Indications Endotoxinaemia
- Focus Pharmacodynamics
- Sponsors NOXXON Pharma AG
- 28 Apr 2014 New trial record